359 related articles for article (PubMed ID: 21344415)
1. Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement.
Sathigari SK; Ober CA; Sanganwar GP; Gupta RB; Babu RJ
J Pharm Sci; 2011 Jul; 100(7):2952-65. PubMed ID: 21344415
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement.
Sanganwar GP; Sathigari S; Babu RJ; Gupta RB
Eur J Pharm Sci; 2010 Jan; 39(1-3):164-74. PubMed ID: 19961931
[TBL] [Abstract][Full Text] [Related]
3. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
Park J; Park HJ; Cho W; Cha KH; Kang YS; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):239-45. PubMed ID: 20599602
[TBL] [Abstract][Full Text] [Related]
4. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
[TBL] [Abstract][Full Text] [Related]
5. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Hu J; Ng WK; Dong Y; Shen S; Tan RB
Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
Parikh T; Sandhu HK; Talele TT; Serajuddin AT
Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
[TBL] [Abstract][Full Text] [Related]
7. Hot-melt extrusion for enhanced delivery of drug particles.
Miller DA; McConville JT; Yang W; Williams RO; McGinity JW
J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869
[TBL] [Abstract][Full Text] [Related]
8. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
[TBL] [Abstract][Full Text] [Related]
9. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of camptothecin (CPT)-loaded folate-conjugated dextran nanoparticles for tumor-targeted drug delivery using supercritical antisolvent method.
Zhao X; Wang D; Zu Y; Jiang R; Zhao D; Li Y; Zu B; Sun Z; Zhang Q
J Control Release; 2011 Nov; 152 Suppl 1():e90-2. PubMed ID: 22195950
[No Abstract] [Full Text] [Related]
11. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
Li C; Li C; Le Y; Chen JF
Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
[TBL] [Abstract][Full Text] [Related]
12. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: effect of various additives.
Kim MS; Kim JS; Hwang SJ
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):230-3. PubMed ID: 20118585
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
[TBL] [Abstract][Full Text] [Related]
17. Effect of a melt agglomeration process on agglomerates containing solid dispersions.
Vilhelmsen T; Eliasen H; Schaefer T
Int J Pharm; 2005 Oct; 303(1-2):132-42. PubMed ID: 16139973
[TBL] [Abstract][Full Text] [Related]
18. Formulation and characterization study of itraconazole-loaded microparticles.
Segale L; Giovannelli L; Mannina P; Pattarino F
Pharm Dev Technol; 2015 Mar; 20(2):153-8. PubMed ID: 24219826
[TBL] [Abstract][Full Text] [Related]
19. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y
Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046
[TBL] [Abstract][Full Text] [Related]
20. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]